ALLR
Allarity Therapeutics, Inc.
There isn't enough reported data to score ALLR yet.
ALLR Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
ALLR's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
ALLR PE Valuation
ALLR has no meaningful PE right now: it lost money over the past year.
ALLR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| -- | |
| -- | |
| Limited | |
| High |
Analysts expect ALLR's earnings, revenue and profitability to hold roughly steady.
ALLR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.80 | +$11.95 |
| Q1 2026 | -$0.74 | +$15.16 |
ALLR is still losing money, but far less than before: $0.80 per share over the past year, against $15.90 at its worst in early 2025.
ALLR Quarterly Revenue
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2026 | -10752% | N/A |
ALLR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2.6M | +$2.9M |
| Q1 2026 | -$4.6M | -$1.9M |
| Q3 2025 | -$3.4M | +$2M |
| Q2 2025 | -$5.5M | +$1.7M |
| Q1 2025 | -$2.7M | -$1.2M |
| Q3 2024 | -$5.4M | -$67K |
| Q2 2024 | -$7.2M | -$4.7M |
| Q1 2024 | -$1.5M | +$1.7M |
ALLR has burned cash in almost every quarter: −$16M over the past year, against −$17M the year before.
ALLR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -57.9K shares |
| 1 year | +2.4% | +367K shares |
ALLR has 16M diluted shares, up 2.4% from a year ago, despite $887,000 in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | $262,000 |
| Q4 2025 | $484,000 |
| Q3 2025 | $141,000 |
ALLR spent $887,000 buying back its own shares over the past year.
ALLR Net Leverage
ALLR's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ALLR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 28.9 | Oversold |
| Stochastic | 15.5 | Oversold |
ALLR's weekly RSI is 29 (oversold) and its Stochastic is 16 (oversold).
ALLR PE vs Healthcare Sector
ALLR has no meaningful PE right now: it lost money over the past year.
ALLR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.95 | 4.2% below |
| 20 week MA | $1.15 | 21% below |
| 50 week MA | $1.19 | 24% below |
| 100 week MA | $1.16 | 22% below |
| 200 week MA | $8,788.2 | 100% below |
ALLR is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
ALLR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $10,054,800.0 | $10,054,800.0 | 0% |
| 2022 | $10,054,800.0 | $186,480.0 | -98% |
| 2023 | $186,480.0 | $330.7 | -100% |
| 2024 | $330.7 | $1.08 | -100% |
| 2025 | $1.08 | $1.07 | -0.9% |
| 2026 YTD | $1.07 | $0.91 | -15% |
ALLR has finished every year since 2021 lower, and it's down 15% so far in 2026.